Market Overview:
The global apoptosis assays market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for apoptosis assays in drug discovery and development, clinical and diagnostic applications, basic research, and stem cell research. Additionally, the growing awareness about apoptosis among researchers is also contributing to the growth of this market. However, factors such as high cost of instruments used for performing apoptosis assays are restraining its growth. On the basis of type, caspase assays accounted for the largest share of the global apoptosis assays market in 2017. This segment is expected to grow at a CAGR of 11% from 2018 to 2030 owing to its wide applicability in drug discovery and development as well as clinical diagnostics applications. Annexin V and cell permeability assay was second-largest type segment with a share of 27% in 2017; it is projected grow at a CAGR close o 12%.
Product Definition:
Apoptosis assays are used to detect and measure apoptosis, or programmed cell death. Apoptosis is important for normal tissue development and homeostasis, as well as for the removal of damaged or aged cells.
Caspase Assays:
Caspase-Glo Assay Kit, Promega Corporation, is a colorimetric assay for measuring the activity of caspases in living cells. The assay uses an exogenous substrate to measure the rate of hydrolysis and provides results in minutes. This makes it an ideal tool for point-of-care research as well as large laboratory experiments involving biological samples.
Annexin V and Cell Permeability Assays:
Annexin V and Cell permeability assays are used for the detection of apoptosis. The process involves the binding of annexin V to an exposed cytosolic protein, which is then transported through the cell membrane into the cytoplasm where it binds to a phosphatidylserine on one of two proteolytic enzymes, either caspase-8 or -9.
Application Insights:
The drug discovery and development segment dominated the global apoptosis assays market in terms of revenue share in 2017. The high prevalence of cancer worldwide coupled with the increasing number of deaths due to cancer is expected to boost the demand for novel drugs with anti-cancer activities during the forecast period. Thus, a large number of companies are engaged in developing new molecules that can prevent tumorigenesis and promote cell survival without causing significant toxicity.
An increase in stem cell research initiatives by various governments across the world is expected to propel market growth over the coming years. Stem cells have tremendous potential as a source for regenerative medicine owing to their ability to self-renew and differentiate into specialized functions cells such as cardiomyocytes, endothelial progenitors, mesenchymal stem cells, and neurogenic precursors among others (1).
Regional Analysis:
North America dominated the global market in 2017. Key factors contributing to its growth include a rise in R&D investments by major companies and increasing focus of key players on this region for commercialization of products. Moreover, high prevalence of neurodegenerative diseases such as Parkinson’s disease, Alzheimer's disease, and Huntington’s disease is expected to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising number of apoptosis-related studies by researchers and increased investment by pharmaceutical companies for drug discovery & development activities in this region. In addition, growing medical tourism industry due to affordable treatment options offered by various countries such as Japan will also boost regional growth over the next eight years.
Growth Factors:
- Increasing research and development expenditure by pharmaceutical and biotechnology companies for the discovery of novel drug candidates
- Rising prevalence of cancer and other diseases that can be treated with apoptosis-inducing drugs
- Growing demand for apoptosis assays in drug discovery and development processes
- Increasing number of collaborations between academic institutions and biotechnology companies for the commercialization of apoptosis assays products
- Proliferation of contract research organizations that offer apoptosis assay services
Scope Of The Report
Report Attributes
Report Details
Report Title
Apoptosis Assays Market Research Report
By Type
Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, Mitochondrial Assays
By Application
Drug Discovery & Development, Clinical & Diagnostic Applications, Basic Research, Stem Cell Research
By Companies
Merck, Thermo Fisher Scientific, Becton Dickinson, Bio-Rad Laboratories, Promega Corporation, Abcam, Bio-Techne, Sartorius, Biotium, Creative Bioarray, Geno Technology, GeneCopoeia, Danaher, GE Healthcare, PerkinElmer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Apoptosis Assays Market Report Segments:
The global Apoptosis Assays market is segmented on the basis of:
Types
Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, Mitochondrial Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery & Development, Clinical & Diagnostic Applications, Basic Research, Stem Cell Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Thermo Fisher Scientific
- Becton Dickinson
- Bio-Rad Laboratories
- Promega Corporation
- Abcam
- Bio-Techne
- Sartorius
- Biotium
- Creative Bioarray
- Geno Technology
- GeneCopoeia
- Danaher
- GE Healthcare
- PerkinElmer
Highlights of The Apoptosis Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
- By Application:
- Drug Discovery & Development
- Clinical & Diagnostic Applications
- Basic Research
- Stem Cell Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Apoptosis Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Apoptosis assays are tests that measure the level of apoptosis in a sample. Apoptosis is the process by which cells die, and an assay that measures apoptotic activity can be used to determine how much damage has been done to a cell or tissue.
Some of the major companies in the apoptosis assays market are Merck, Thermo Fisher Scientific, Becton Dickinson, Bio-Rad Laboratories, Promega Corporation, Abcam, Bio-Techne, Sartorius, Biotium, Creative Bioarray, Geno Technology, GeneCopoeia, Danaher, GE Healthcare, PerkinElmer.
The apoptosis assays market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Apoptosis Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Apoptosis Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Apoptosis Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Apoptosis Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Apoptosis Assays Market Size & Forecast, 2018-2028
4.5.1 Apoptosis Assays Market Size and Y-o-Y Growth
4.5.2 Apoptosis Assays Market Absolute $ Opportunity
Chapter 5 Global Apoptosis Assays Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Apoptosis Assays Market Size Forecast by Type
5.2.1 Caspase Assays
5.2.2 Annexin V and Cell Permeability Assays
5.2.3 DNA Fragmentation Assays
5.2.4 Mitochondrial Assays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Apoptosis Assays Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Apoptosis Assays Market Size Forecast by Applications
6.2.1 Drug Discovery & Development
6.2.2 Clinical & Diagnostic Applications
6.2.3 Basic Research
6.2.4 Stem Cell Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Apoptosis Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Apoptosis Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Apoptosis Assays Analysis and Forecast
9.1 Introduction
9.2 North America Apoptosis Assays Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Apoptosis Assays Market Size Forecast by Type
9.6.1 Caspase Assays
9.6.2 Annexin V and Cell Permeability Assays
9.6.3 DNA Fragmentation Assays
9.6.4 Mitochondrial Assays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Apoptosis Assays Market Size Forecast by Applications
9.10.1 Drug Discovery & Development
9.10.2 Clinical & Diagnostic Applications
9.10.3 Basic Research
9.10.4 Stem Cell Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Apoptosis Assays Analysis and Forecast
10.1 Introduction
10.2 Europe Apoptosis Assays Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Apoptosis Assays Market Size Forecast by Type
10.6.1 Caspase Assays
10.6.2 Annexin V and Cell Permeability Assays
10.6.3 DNA Fragmentation Assays
10.6.4 Mitochondrial Assays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Apoptosis Assays Market Size Forecast by Applications
10.10.1 Drug Discovery & Development
10.10.2 Clinical & Diagnostic Applications
10.10.3 Basic Research
10.10.4 Stem Cell Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Apoptosis Assays Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Apoptosis Assays Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Apoptosis Assays Market Size Forecast by Type
11.6.1 Caspase Assays
11.6.2 Annexin V and Cell Permeability Assays
11.6.3 DNA Fragmentation Assays
11.6.4 Mitochondrial Assays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Apoptosis Assays Market Size Forecast by Applications
11.10.1 Drug Discovery & Development
11.10.2 Clinical & Diagnostic Applications
11.10.3 Basic Research
11.10.4 Stem Cell Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Apoptosis Assays Analysis and Forecast
12.1 Introduction
12.2 Latin America Apoptosis Assays Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Apoptosis Assays Market Size Forecast by Type
12.6.1 Caspase Assays
12.6.2 Annexin V and Cell Permeability Assays
12.6.3 DNA Fragmentation Assays
12.6.4 Mitochondrial Assays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Apoptosis Assays Market Size Forecast by Applications
12.10.1 Drug Discovery & Development
12.10.2 Clinical & Diagnostic Applications
12.10.3 Basic Research
12.10.4 Stem Cell Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Apoptosis Assays Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Apoptosis Assays Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Apoptosis Assays Market Size Forecast by Type
13.6.1 Caspase Assays
13.6.2 Annexin V and Cell Permeability Assays
13.6.3 DNA Fragmentation Assays
13.6.4 Mitochondrial Assays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Apoptosis Assays Market Size Forecast by Applications
13.10.1 Drug Discovery & Development
13.10.2 Clinical & Diagnostic Applications
13.10.3 Basic Research
13.10.4 Stem Cell Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Apoptosis Assays Market: Competitive Dashboard
14.2 Global Apoptosis Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Thermo Fisher Scientific
14.3.3 Becton Dickinson
14.3.4 Bio-Rad Laboratories
14.3.5 Promega Corporation
14.3.6 Abcam
14.3.7 Bio-Techne
14.3.8 Sartorius
14.3.9 Biotium
14.3.10 Creative Bioarray
14.3.11 Geno Technology
14.3.12 GeneCopoeia
14.3.13 Danaher
14.3.14 GE Healthcare
14.3.15 PerkinElmer
